AbbVie Inc. (ABBV34)

Overview

AbbVie Inc. is a global pharmaceutical company engaged in the discovery, development, manufacture, and sale of a wide range of pharmaceutical products aimed at treating various diseases and medical conditions. Since its incorporation in 2012, the company has established a significant presence in the pharmaceutical industry through its broad portfolio of products, innovative therapies, and strategic collaborations. Headquartered in North Chicago, Illinois, AbbVie operates worldwide, addressing some of the most challenging health issues with a focus on research and patient care.

Products and Services

• Humira: An injection used for the treatment of autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum.
• Skyrizi: Treats moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease.
• Rinvoq: Used for rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease.
• Imbruvica: Provides treatment for adult patients with various forms of blood cancers.
• Epkinly: Serves as a therapy for lymphoma.
• Elahere: Utilized in the treatment of cancer.
• Venclexta/Venclyxto: Offers treatment options for blood cancers.
• Facial Injectables, Plastics and Regenerative Medicine: A range of cosmetic and regenerative treatments including body contouring and skincare products.
• Botox Therapeutic: Used for various therapeutic purposes beyond cosmetic enhancements.
• Vraylar: Medication for depressive disorder.
• Duopa and Duodopa: Advanced treatment options for Parkinson's disease.
• Ubrelvy: Provides acute treatment for migraine in adults.
• Qulipta: Treats episodic and chronic migraine.
• Ozurdex: Used for the treatment of eye diseases.
• Lumigan/Ganfort and Alphagan/Combigan: Helps in the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
• Restasis: Increases tear production to address eye dryness.
• Mavyret/Maviret: Treats chronic hepatitis C virus genotype 1-6 infection.
• Creon: A pancreatic enzyme therapy.
• Lupron: Used for treating advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids.
• Linzess/Constella: Treats irritable bowel syndrome with constipation and chronic idiopathic constipation.
• Synthroid: A prescription for hypothyroidism.

In addition to these products, AbbVie is engaged in numerous collaborations with entities like Calico Life Sciences LLC, REGENXBIO Inc., Janssen Biotech, Inc., Evolveimmune Therapeutics, Inc., Genentech, Inc., and Tentarix Biotherapeutics, LP, aiming to explore and expand its treatment offerings across various medical fields.